Systems Biology of Amyotrophic Lateral Sclerosis (ALS)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorViome
About this trial
The goal of this observational study is to identify molecular features in multiple clinical samples and/or the patient environment that are associated with ALS. Participants will collect biological samples and answer questionnaires regarding their health at each appointment with their ALS practitioner.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patient of Dr. Espíndola at UFSC
Disqualifiers
None
Trial population
ALS cohort: Patients of Dr. Espíndola at UFSC Control cohort: Participants from the general population
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
20 Participants
are grouped into 2 trial groupsGroup A: ALS Cohort
Group B: Control Cohort
Trial outcomes
Primary outcomes
1
Molecular features of biological samples that are predictive of ALS progression
Time frame
We will collect samples and health data from each participant from the time of diagnosis to their death or study termination, whichever comes sooner. Specific time frame: We will collect outcome measures through study completion, an average of 3 years.Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Viome
Lead sponsor
Universidade Federal de Santa Catarina
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: